This is a news story, published by CNBC, that relates primarily to Bavarian Nordic news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
biotech company Bavarian Nordic. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest last mpox outbreak news, Danish krone news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
mpox vaccinesCNBC
•
87% Informative
Shares of Danish biotech company Bavarian Nordic jumped more than 12% in early deals on Thursday after it reported stronger-than-expected earnings.
The company also announced a bumper 440,000 dose contract to supply mpox vaccines to an undisclosed European country.
Comes after the World Health Organization last week declared mpox a global public health emergency.
VR Score
93
Informative language
94
Neutral language
75
Article tone
formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links